Palisade Bio, Inc. · NASDAQ:PALI
Williams Donald Allen bought 20,000 Palisade Bio, Inc. shares (Form 4)
Traded Oct 1 to Oct 2, 2026 · Filed Oct 5, 2026
From Oct 1 to Oct 2, 2026, Williams Donald Allen (Director) bought 20,000 Palisade Bio, Inc. shares at an average US$1.44 for US$28,800, leaving 1,590,294 shares. Filed Oct 5, 2026 (Form 4).
- Bought
- 20,000 shares
- Price
- US$1.44 average (US$1.42 to US$1.46)
- Value
- US$28,800
- Holding after
- 1,590,294 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | Common Stock | Buy | 10,000 | US$1.42 | 1,580,294 | Direct |
| Oct 2, 2026 | Common Stock | Buy | 10,000 | US$1.46 | 1,590,294 | Direct |
Source
Related
- Palisade Bio, Inc.
- Williams Donald Allen
- Palisade Bio, Inc. shareholders
- Form 4 · Williams Donald Allen · Jun 12, 2026
- Form 4 · Finley John David · Oct 7, 2026
- Form 4 · Jones Mitchell Lawrence · Oct 7, 2026
- Form 4 · Finley John David · Aug 21, 2026
- Schedule 13G/A · Commodore Capital LP · Aug 14, 2026
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · Aug 13, 2026